NEW YORK (GenomeWeb News) – The UK plans to launch a new government-owned company focused on applying genomics technologies in clinical care that will oversee the government’s effort to sequence 100,000 genomes, mostly of patients, manage a massive database to match DNA and clinical data, and handle other genome-focused health projects.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.